Hôpital ROBERT DEBRE - ORL Pédiatrique
Paris, 75020, France
NCT Number: NCT01022944
Rationale: Bacterial biofilms are defined as an assemblage of bacterial cells enclosed in a self-produced glycocalyx matrix. Adherence on surfaces, and resistance to both antibiotic treatments and host defenses are ones of the major clinical features of bacterial biofilms. Hence, biofilm formations represent a serious clinical problem: they persist in human tissues and play a role in a large number of chronic and resistant infections. It has been estimated that more than 65% of all human bacterial infections involve biofilms. Recently, the investigators have demonstrated the presence of mucosal bacterial biofilms in adenoid tissues removed during routine adenoidectomy. Bacterial biofilms were visualized using Confocal Laser Scanning Microscopy (CLSM) with a technique of double staining showing both the bacterial cells and the glycocalyx matrix. Although this study clearly established that adenoids tissues can harbour mucosal biofilms, the prevalence of 54% the investigators found suggested that some groups of children may contain more biofilm formations than others. In an effort to relate the findings of mucosal biofilm with the clinical presentation, the investigators have designed the present work to compare the prevalence of mucosal biofilms in adenoidectomy specimens in two groups: one group of children with chronic otitis media (COM) with effusion versus another group of children without any COM, having adenoids removed for chronic obstruction.
Looking for future studies?
Notify Me18 month–10 year
All sexes
Interventional
Not applicable
Paris, 75020, France
The aim of this case-control study is to compare the prevalence of biofilms formations in adenoid tissues of children with COM versus a control group without any COM.
Design: This is a monocentric, prospective, unrandomized case-control study comparing the prevalence of biofilm formations in adenoid tissues of two groups.
Clinical research study without direct medical benefit: during routine adenoidectomy, specimens are not used and thrown away. This study do not modify the common management of included children.
Number of subjects required: A considered approach of simple size calculation have been made using a method proposed by MIETINEN for Mc NEMAR Chi2 test. Simple size N=104 will allow 80% power to detect different of 20% (absolute), considering a total percentage of discordance pair at 30 %.
Expected results: a higher prevalence (30% estimation) of biofilm formations in group 1 in comparison with that in group 2 would be the first clinical research study bringing understanding of the role of adenoid tissues by harboring mucosal biofilms in otitis prone children.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Children with chronic middle ear effusion having adenoidectomy.
Children without chronic middle ear effusion as a control group having adenoids removed for chronic obstruction.
Time frame: at 2 years
Time frame: during the study
Assistance Publique - Hôpitaux de Paris
Other
Prevalence of Mucosal Biofilm Formations in Adenoidectomy Specimens. A Case Control Study
Acronym: BOLERO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07721610
Ear Diseases, Hearing Disorders
Roma, Italy
View Trial DetailsNCT07242001
Ear Diseases, OTITIS MEDIA WITH EFFUSION
Jakarta Pusat, DKI Jakarta, Indonesia
View Trial DetailsNCT06967506
Breathing Exercise, Ear Diseases
Uşak, Merkez, Turkey (Türkiye)
View Trial DetailsNCT07122999
Disease Attributes, Ear Diseases
Busan, Seo-Gu, South Korea
View Trial Details